Approval · Notice of Compliance 7833 · 2006
AMARYL: Notice of Compliance 7833
Issued March 17, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7833
- Date
- March 17, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Oral hypoglycemic (sulfonylurea)
Products in this notice
Medicinal ingredients
- GLIMEPIRIDE 1 MG per TAB
- GLIMEPIRIDE 2 MG per TAB
- GLIMEPIRIDE 4 MG per TAB